Published in Gene Ther on October 01, 2000
Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (2010) 2.55
Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol (2002) 1.09
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer. Curr Gene Ther (2009) 0.86
Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol (2004) 0.85
Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.78
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ (2008) 2.84
Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol (1992) 2.32
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun (1990) 2.31
Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther (2000) 1.81
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol (1982) 1.74
Mesotheliomas following exposure to asbestos used in railroads: 130 Italian cases. Med Lav (1996) 1.38
Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br J Pharmacol (1980) 1.36
The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br J Pharmacol (1981) 1.34
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia (2002) 1.33
Structural elucidation of a new cytotoxin isolated from mussels of the Adriatic sea. J Org Chem (2001) 1.30
Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol (1995) 1.16
Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett (1997) 1.15
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol (1987) 1.01
Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids (1996) 1.00
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol (1999) 0.99
Multiple control of inflammation by glucocorticoids. Agents Actions (1986) 0.99
New cytotoxic steroids from the marine sponge Dysidea fragilis coming from the lagoon of Venice. Steroids (1995) 0.97
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol (1999) 0.96
Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEBS Lett (1998) 0.95
Thiazolidinediones are partial agonists for the glucocorticoid receptor. Endocrinology (2008) 0.94
The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins. Agents Actions (1985) 0.92
Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB. Br J Pharmacol (1998) 0.92
Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. FEBS Lett (2001) 0.92
Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci (1996) 0.91
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. Cell Death Differ (2013) 0.89
Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem Pharmacol (1998) 0.88
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.87
Modulation of granuloma formation by endogenous nitric oxide. Eur J Pharmacol (1994) 0.87
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflamm Res (2000) 0.87
Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol (1995) 0.86
Synthesis of novel anti-inflammatory peptides derived from the amino-acid sequence of the bioactive protein SV-IV. Eur J Biochem (2001) 0.86
Glycolipids from sponges. VII. Simplexides, novel immunosuppressive glycolipids from the Caribbean sponge Plakortis simplex. Bioorg Med Chem Lett (1999) 0.85
HSF1/hsp72 pathway as an endogenous anti-inflammatory system. FEBS Lett (2001) 0.84
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alpha by lipopolysaccharide-activated J774 macrophages. Inflamm Res (1999) 0.84
Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat. Br J Pharmacol (1997) 0.82
Activation of nuclear transcription factor kappaB in rat carrageenin-induced pleurisy. Eur J Pharmacol (1999) 0.82
Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun (1995) 0.81
Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone. Br J Pharmacol (2014) 0.81
Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function. Br J Pharmacol (2013) 0.80
5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. Life Sci (1995) 0.80
Cytotoxic saponins from bulbs of Allium porrum L. J Agric Food Chem (2000) 0.80
Protective role of nuclear factor kappa B against nitric oxide-induced apoptosis in J774 macrophages. Cell Death Differ (2001) 0.80
S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. Br J Pharmacol (2015) 0.80
Nuclear factor-kappaB activation mediates inducible nitric oxide synthase expression in carrageenin-induced rat pleurisy. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.79
Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. Clin Exp Rheumatol (2002) 0.79
Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids. Pharmacol Res (1992) 0.79
Nitric oxide prevents inducible cyclooxygenase expression by inhibiting nuclear factor-kappa B and nuclear factor-interleukin-6 activation. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.79
Cloricromene inhibits the induction of nitric oxide synthase. Eur J Pharmacol (1993) 0.79
Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin-A from rat peritoneal cells. Br J Pharmacol (1989) 0.79
Role of nuclear factor-kappaB in a rat model of vascular injury. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.79
Nitric oxide inhibits neutrophil infiltration in the reverse passive arthus reaction in rat skin. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.79
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum. J Nat Prod (1997) 0.79
Glucocorticoid induction of angiotensin converting enzyme. Agents Actions (1986) 0.78
Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced protein(s) in lipopolysaccharide-stimulated J774 cells. Eur J Pharmacol (1997) 0.78
Selective inhibition of inflammatory reactions by vasocortin and antiflammin 2. Prog Clin Biol Res (1990) 0.77
Inhibition of nuclear factor-kappaB prevents the loss of vascular tone in lipopolysaccharide-treated rats. Eur J Pharmacol (1999) 0.76
Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1998) 0.76
Mesotheliomas following exposure to asbestos used in sugar refineries: report of 12 Italian cases. Med Lav (1996) 0.76
Transcription factor decoy oligodeoxynucleotides to nuclear factor-kappaB inhibit reverse passive Arthus reaction in rat. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.76
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coli. Eur J Biochem (1993) 0.75
Modulation of macrophage activation by prostaglandins. Mediators Inflamm (1996) 0.75
Cloricromene in endotoxemia: role of NF-kappaB. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.75
Immunostimulant (1 --> 3)-D-glucans from the cell wall of Cryphonectria parasitica (Murr.) Barr strain 263. Carbohydr Res (2000) 0.75
Synthesis and biological evaluation of proline derivatives as potential angiotensin converting enzyme inhibitor. Boll Soc Ital Biol Sper (1996) 0.75
The inhibition of platelet aggregation by activated macrophages is blocked by dexamethasone. Pharmacol Res (1993) 0.75
Characterization of vasocortin-like proteins induced by dexamethasone in endothelial cells. Eur J Pharmacol (1993) 0.75
Synthesis and antinociceptive activity of peptides related to interleukin-1 beta 193-195 Lys-Pro-Thr. Biopolymers (1996) 0.75
Phospholipase A2 and lipocortins, antiphospholipase proteins. Methods Enzymol (1988) 0.75